Chemo and Keytruda: Better Together

Pairing an immunotherapy drug with chemo significantly prolonged the lives of newly diagnosed advanced lung cancer patients compared to chemo alone, found a much-anticipated new study. The findings, published in the New England Journal of Medicine, could mean more of these patients will replace chemo with an FDA-approved Keytruda-chemo combination.

Immunotherapy, which sics the immune system on cancer cells, is “dramatically changing the standard of care for lung cancer,” said Leena Gandhi, an at NYU Langone Health oncologist.

The findings are among several lung cancer studies rolled out Monday on what’s being called the “Super Bowl of lung cancer immunotherapy.”

The Washington Post

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top